Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 432 million compared to CNY 474.35 million a year ago. Revenue was CNY 432 million compared to CNY 474.35 million a year ago.

Net income was CNY 69.35 million compared to CNY 93.93 million a year ago. Basic earnings per share from continuing operations was CNY 0.479 compared to CNY 0.6487 a year ago. Diluted earnings per share from continuing operations was CNY 0.479 compared to CNY 0.6487 a year ago.